Sign inJoin waitlistJoin the waitlist

Saeed Sadeghi

Clinical Professor in the Division of Hematology-Oncology · UCLA School of Medicine

Credentials: · · · · ·

History

UCLA School of Medicine
Present

UCLA School of Medicine
Until 2005
LAC + USC Medical Center
Until 2002
LAC + USC Medical Center
Until 2000
Saint Louis University School of Medicine
1999
UCLA

Research

Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer
Journal of Clinical Oncology · 2009 · 787 citations
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Journal of Clinical Oncology · 2018 · 536 citations
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre,…
The Lancet. Gastroenterology & hepatology · 2021 · 352 citations

Richard Finn
16 papers
Vatche Agopian
12 papers
Ronald Busuttil
10 papers
Yi-Te Lee
6 papers · 2 as a fellow
Sammy Saab
5 papers
Steven-Huy Han
5 papers
BT
Benjamin Tran
4 papers · 4 as a resident
CC
Colin Court
4 papers · 4 as a fellow
Fady Kaldas
4 papers
James Tomlinson
4 papers
Jasmine Wang
4 papers
MP
Michael Press
4 papers

Clinical trials

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Novartis Pharmaceuticals
2025–2028
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Site PI · Recruiting · Phase 1
Regor Pharmaceuticals Inc.
2022–2027